Activated platelets as a possible early marker to predict clinical efficacy of leukocytapheresis in severe ulcerative colitis patients
Authors:
- 24 July 2006
- journal article
- research article
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 41 (6) , 524-532
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Platelet Activation Markers in Patients with Venous Thromboembolism without Predisposing FactorsPathophysiology of Haemostasis and Thrombosis, 2005
- Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammationPlatelets, 2005
- CellsorbaTherapeutic Apheresis and Dialysis, 2003
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2002
- Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel diseaseJournal of Gastroenterology, 1995
- Human neutrophil Fc receptor-mediated adhesion under flow: a hollow fibre model of intravascular arrestClinical and Experimental Immunology, 1995
- Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid TherapyNew England Journal of Medicine, 1994
- PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytesCell, 1989
- Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.BMJ, 1989
- Platelet count: a simple measure of activity in Crohn's disease.BMJ, 1983